BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34040951)

  • 1. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
    Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
    Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
    Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
    Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
    Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
    Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
    Sisay M; Amare F; Hagos B; Edessa D
    J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique.
    Jessen N; Sharma A; Jones J; Auala T; Boladuadua S; Jingi A; Ferrer J; Mocumbi AO
    Glob Heart; 2023; 18(1):8. PubMed ID: 36874443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
    Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
    Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
    Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
    Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.
    Dzudie A; Njume E; Abanda M; Aminde L; Hamadou B; Dzekem B; Azabji M; Doualla MS; Ngowe M; Kengne AP
    PLoS One; 2020; 15(3):e0229307. PubMed ID: 32130252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
    Kibirige D; Atuhe D; Kampiire L; Kiggundu DS; Donggo P; Nabbaale J; Mwebaze RM; Kalyesubula R; Lumu W
    Int J Equity Health; 2017 Aug; 16(1):154. PubMed ID: 28836972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
    Tadesse T; Abuye H; Tilahun G
    BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia.
    Ooms GI; Kibira D; Reed T; van den Ham HA; Mantel-Teeuwisse AK; Buckland-Merrett G
    BMC Public Health; 2020 Jul; 20(1):1053. PubMed ID: 32620159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.